ANNUAL REPORT 2021

LUNDBECK ANNUAL REPORT 2021 = CONTENTS 38/111 SUSTAINABILITY AND COMPLIANCE In this section we present a short summary of aspirations, management, due diligence and targets. We publish an annual Sustainability Report at the same time as the release of the Annual Report. Here you can find detailed information and an Environmental, Social and Governance (ESG) factbook. Our mandatory annual statutory reporting on sustainability and diversity of management in accordance with section 99a, 99b, 99d and 107d in the Danish Financial Statements Act, and the EU Sustainable Finance Taxonomy is in our Sustainability Report*. Lundbeck's sustainability activities aim to mitigate risks and adverse impacts related to our business activities and contribute to solving societal challenges where we can. We remain committed to the UN Global Compact Principles and contribute to addressing seven of the Sustainable Development Goals. OUR MOST MATERIAL SUSTAINABILITY ISSUES Sustainability is an imperative to Lundbeck and an integral part of our strategy and culture. Our most material sustainability issues are reflected in the SDGs that we significantly impact. Our biggest contribution to sustainable development, is our medical treatments and the good health and wellbeing they bring to people. Closely related to this is being compliant in all aspects of patient safety and taking a strict stance on anti- corruption in our collaborations with business partners, healthcare professionals and regulators. Our other material issues include taking a leading role in climate action, environmental management in general, and promoting an ethical, safe, motivating and inclusive culture in our entire value chain. MANAGING SUSTAINABILITY Executive Management governs the sustainability strategy and reviews progress on targets and approves new initiatives in quarterly sessions. We continuously set ambitious targets, report progress on the targets and disclose a set of externally reviewed non-financial indicators across all areas of corporate sustainability and business ethics compliance. SUSTAINABILITY REVIEW OF 2021 Our activities related to the Access to Brain Health strategy gained momentum in 2021. We successfully completed the first year of our product donation partnership with International Health Partners (IHP), shipping medicine for treatment of more than 900 patients at NGO clinics in Lebanon, Gaza and the West Bank. In December, we signed a Letter of Intent with IHP covering the next three year outlining our shared aim to increase access to brain health to vulnerable people in the Middle east and Africa region. One of the 2021 target for business ethics was that all employees at work globally should complete the Annual Code of Conduct training. This was achieved with a 99.7% completion rate. We announced last year that we will have net zero emissions no later than 2050 and that we have set a new Science-Based target to reduce carbon emissions drastically over the next 15 years. We will reduce carbon emissions from production and company car fleet (scope 1 and 2) by almost two-thirds, and work with our suppliers to reduce our carbon footprint outside our premises (scope 3) by nearly a fifth. We can report significant progress on reducing scope 1 and 2 and have achieved a 16% reduction against the baseline year 2019. This is mainly due to fewer emission from company cars, as sales employees have been less on the road due to the COVID-19 pandemic. https://www.lundbeck.com/content/dam/lundbeck-com/masters/global- site/pdf/Sustainability_Report_2021.pdf

View entire presentation